Biotechnology policies and performance in central and eastern Europe

article


Senker, J.

Enzing, C.

Reiss, T.
This paper assesses how far ten Central and Eastern European (CEE) countries have 'caught up' in biotechnology on the basis of information about the policies and funding for biotechnology research and commercialisation from 2002-2005 and on the research and commercialisation performance of these countries. The countries that are covered are Bulgaria, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Poland, Romania, the Slovak Republic and Slovenia. The countries are grouped into three clusters, with similar performances in biotechnology as the basis for distinguishing the shared characteristics which could explain performance. Government science and technology policy is found to be a significant factor in explaining biotechnology performance. Copyright © 2008 Inderscience Enterprises Ltd.
Topics


















































Biotechnology policiesCentral and eastern European countriesCommercialisation performanceResearch performancePublic policyResearchTechnologyBulgariaCentral and Eastern Europe (CEE)CommercialisationCzech republicEstonia (CO)EuropeanGovernment scienceHungaryLithuaniaRomaniaSignificant factorSlovak RepublicSloveniaBiotechnologybiotechnologycommercializationindustrial policyperformance assessmentscience and technologyadvertizingarticlebiotechnologyEastern EuropeEuropegovernmenthealth care policyhealth care systemmedical researchBaltic StatesBulgariaCentral EuropeCzech RepublicEstoniaEurasiaEuropeHungaryLatviaLithuaniaNorthern EuropePolandRomaniaSlovakiaSloveniaSouthern Europe
TNO Identifier
240884
Repository link
https://resolver.tno.nl/uuid:979a592e-2aab-476e-b8f6-ad7a73f56bf4
ISSN
09636048
Source
International Journal of Biotechnology, 10(4), pp. 341-362.
Pages
341-362
Files
To receive the publication files, please send an e-mail request to TNO Repository.